Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículo Destacado en trastornos del movimiento

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Enfermedad de Parkinson

2053 ARTíCULOS , VIENDO DEL 31 AL 45

PUBMED

Cat Scratch Disease-associated Encephalitis Followed by Parkinsonism

Nakamura M, Ura S, Yabe I, Otsuki M, Soma H, Ogata A.

Intern Med. 2022 Oct 15;61(20):3115-3120. doi: 10.2169/internalmedicine.9047-21. Epub 2022 Mar 19.

0

0

0

PUBMED

Brain-Derived Neurotrophic Factor: A Novel Dynamically Regulated Therapeutic Modulator in Neurological Disorders

Sharma V, Singh TG, Kaur A, Mannan A, Dhiman S.

Neurochem Res. 2022 Oct 29. doi: 10.1007/s11064-022-03755-1. Online ahead of print.

0

0

0

PUBMED

Long-term effects of safinamide adjunct therapy on levodopa-induced dyskinesia in Parkinson's disease: post-hoc analysis of a Japanese phase III study

Hattori N, Kamei T, Ishida T, Suzuki I, Nomoto M, Tsuboi Y.

J Neural Transm (Vienna). 2022 Oct;129(10):1277-1287. doi: 10.1007/s00702-022-02532-2. Epub 2022 Aug 24.

0

0

0

PUBMED

Cotard syndrome during the withdrawal of high-dose antiparkinsonian drugs in a patient with Parkinson's disease

Morioka D, Kobayashi R, Kawakatsu S, Suzuki A.

Asian J Psychiatr. 2022 Oct 4;78:103286. doi: 10.1016/j.ajp.2022.103286. Online ahead of print.

0

0

0

PUBMED

Shifts in the eye-centered frame of reference may underlie saccades, visual perception, and eye-hand coordination

Zhang L, Guberman S, Feldman AG.

J Neurophysiol. 2022 Oct 1;128(4):1025-1039. doi: 10.1152/jn.00531.2021. Epub 2022 Sep 7.

0

0

0

PUBMED

Research progress on neuromolecular imaging of REM sleep behavior disorder

Geng C, Zhang H.

Front Neurol. 2022 Oct 10;13:1009907. doi: 10.3389/fneur.2022.1009907. eCollection 2022.

0

0

0

PUBMED

Neuron Protection by EDTA May Explain the Successful Outcomes of Toxic Metal Chelation Therapy in Neurodegenerative Diseases

Ferrero ME.

Biomedicines. 2022 Oct 4;10(10):2476. doi: 10.3390/biomedicines10102476.

0

0

0

PUBMED

Benefits of task-specific movement program on en bloc turning in Parkinson's disease: A randomized controlled trial

Khobkhun F, Hollands M, Tretriluxana J, Srivanitchapoom P, Richards J, Ajjimaporn A.

Physiother Res Int. 2022 Oct;27(4):e1963. doi: 10.1002/pri.1963. Epub 2022 Jun 19.

0

0

0

PUBMED

A systematic review of local field potential physiomarkers in Parkinson's disease: from clinical correlations to adaptive deep brain stimulation algorithms

van Wijk BCM, de Bie RMA, Beudel M.

J Neurol. 2022 Oct 8. doi: 10.1007/s00415-022-11388-1. Online ahead of print.

0

0

0

PUBMED

Clocking the age of Parkinson disease onset

Wood H.

Nat Rev Neurol. 2022 Oct;18(10):575. doi: 10.1038/s41582-022-00719-5.

0

0

0

PUBMED

Ubiquitin C-terminal hydrolase L1 (UCHL1), a double-edged sword in mammalian oocyte maturation and spermatogenesis

Yang D, Lu Q, Peng S, Hua J.

Cell Prolif. 2022 Oct 11:e13347. doi: 10.1111/cpr.13347. Online ahead of print.

0

0

0

PUBMED

Involvement of the G-Protein-Coupled Estrogen Receptor-1 (GPER) Signaling Pathway in Neurodegenerative Disorders: A Review

Upadhayay S, Gupta R, Singh S, Mundkar M, Singh G, Kumar P.

Cell Mol Neurobiol. 2022 Oct 28. doi: 10.1007/s10571-022-01301-9. Online ahead of print.

0

0

0

PUBMED

Effectiveness of gait aid prescription for improving spatiotemporal gait parameters and associated outcomes in community-dwelling older people: a systematic review

Lee DA, Dissanayaka T, Burton E, Meyer C, Hunter SW, Suttanon P, Ekegren CL, Stout JC, Dawes H, Hill KD.

Disabil Rehabil. 2022 Oct;44(21):6139-6154. doi: 10.1080/09638288.2021.1958930. Epub 2021 Aug 10.

0

0

0

PUBMED

Modulation of cellular redox environment as a novel therapeutic strategy for Parkinson's disease

Deus CM, Teixeira J, Raimundo N, Tucci P, Borges F, Saso L, Oliveira PJ.

Eur J Clin Invest. 2022 Oct;52(10):e13820. doi: 10.1111/eci.13820. Epub 2022 Jun 13.

0

0

0

PUBMED

Reply to "Risk reduction of Parkinson's disease by caffeinated beverage consumption"

Belvisi D, Costanzo M, Pellicciari R, Modugno N, Nicoletti A, Fabbrini G, Tinazzi M, Defazio G, Berardelli A.

Parkinsonism Relat Disord. 2022 Oct;103:15-16. doi: 10.1016/j.parkreldis.2022.08.010. Epub 2022 Aug 17.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy